Mizuho Markets Americas’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.8M Sell
393,081
-930,463
-70% -$63.4M 0.48% 57
2026
Q1
$85.5M Buy
1,323,544
+54,871
+4% +$3.87M 2.34% 10
2025
Q4
$85.4M Buy
1,268,673
+926,526
+271% +$62.3M 1.65% 13
2025
Q3
$25.1M Sell
342,147
-55,186
-14% -$3.67M 0.47% 47
2025
Q2
$20.7M Buy
397,333
+23,160
+6% +$1.32M 0.63% 36
2025
Q1
$23.9M Sell
374,173
-93,110
-20% -$5.41M 0.49% 47
2024
Q4
$22.3M Buy
467,283
+91,837
+24% +$4.71M 0.4% 53
2024
Q3
$21.5M Sell
375,446
-62,660
-14% -$3.59M 0.44% 42
2024
Q2
$22.9M Sell
438,106
-18,530
-4% -$813K 0.55% 33
2024
Q1
$18.6M Buy
456,636
+9,975
+2% +$374K 0.46% 35
2023
Q4
$16.5M Buy
446,661
+43,998
+11% +$1.66M 0.46% 31
2023
Q3
$15.4M Sell
402,663
-120
-0% -$4.92K 0.54% 33
2023
Q2
$14.5M Buy
402,783
+43,600
+12% +$1.49M 0.95% 9
2023
Q1
$13.7M Buy
359,183
+83,915
+30% +$3.94M 0.55% 26
2022
Q4
$15.7M Sell
275,268
-83,450
-23% -$4.27M 0.92% 25
2022
Q3
$14.2M Buy
+358,718
New +$15.9M 0.62% 36

Other funds holding HALO

Mizuho Markets Americas's HALO Position: Q2 2026 in Review

Mizuho Markets Americas reduced its Halozyme (HALO) stake by 70% in Q2 2026, selling an estimated $63.4M and leaving 393,081 shares worth $30.8M. The position accounts for 0.48% of the portfolio, ranked #57.

Mizuho Markets Americas first reported a position in HALO in Q3 2022 and has held it in 16 quarters since. The position peaked at $85.5M in Q1 2026. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Mizuho Markets Americas held 393,081 shares of Halozyme worth $30.8M as of Q2 2026.
  • Mizuho Markets Americas sold 930,463 Halozyme shares in Q2 2026, an estimated $63.4M.
  • Halozyme made up 0.48% of Mizuho Markets Americas's portfolio in Q2 2026, its #57 holding.
  • Mizuho Markets Americas first reported a position in Halozyme in Q3 2022 and has held it in 16 quarters since.
  • Mizuho Markets Americas's Halozyme position peaked at $85.5M in Q1 2026.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Mizuho Markets Americas's 13F filing for Q2 2026, filed 24 Jul 2026.